Ultimately, BioNTech’s mission is to make treatments that are optimized not only to specific patient needs, but also to time and place.
FDA Approves Human Clinical Trials of a Possible CRISPR-Based HIV Cure
“A CRISPR-Cas9 gene editing technology that has shown promise in clearing HIV from mice is headed into human testing,” reports Fierce Biotech:
We don’t like to throw the word “cure” around here. But Excision BioTherapeutics thinks the therapy could rep…
Gingko Bioworks, valued at $15B, begins trading today: Here’s how their business works
Gingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Gingko’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s also one of the biggest SPAC deals done to date — Gingko […]
African genomics startup 54gene raises $25M to expand precision medicine capabilities
Less than 3% of genetic material used in global pharmaceutical research is from Africa. The staggering gap is quite surprising because Africans and people of African descent are reported to be more genetically diverse than any other population. Since launching in 2019, African genomics startup 54gene has been at the forefront of bridging this divide […]
How Colossal sold investors on a quest to resurrect a woolly mammoth
There are a growing number of companies interested in CRISPR’s potential to upend medicine. It’s probably safe to say there’s only one company interested in using the gene-editing system to create a living, breathing woolly mammoth. Or, at least, something pretty close to it. That’s the primary mission of a new company called Colossal. Co-founded […]
Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn
The CRISPR-based biotech startup Mammoth Biosciences is officially a unicorn, the company says. The billion dollar valuation comes on the back of a $150 million series D round led by Redmile Group, with participation from Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield, Decheng Capital, Plum Alley and NFX. Combined with a late […]
Teatis, low-sugar superfood powders developer for diabetics, closes seed round
A serial entrepreneur Hiroshi Takatoh recognized the need for convenient and nutritious food for critically ill consumers after losing his late wife to cancer. Takatoh founded Teatis, a plant-based sugar blocking superfood powder for diabetic consumers, in 2017 in stealth mode and went fully operational in April 2021 by teaming up with a group of […]
Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products
Emulate Inc., a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in a “roadmap” for developing model organ systems created to fit drug makers’ needs and bring the idea of an organ-on-a-chip into use in the lab. […]
Theranos Founder Elizabeth Holmes On Trial As Jury Selection Begins
An anonymous reader quotes a report from Ars Technica, written by Tim De Chant: Nearly a decade ago, Theranos touted a revolutionary diagnostic device that could run myriad medical tests without having to draw blood through a needle. Today, the startup…
ラーメンは依存性が高い食べ物である
NEWSポストセブンの記事によると、ラーメンは食物依存症になりやすい中毒性の高い食品なのだそうだ。薬食フードライフ研究家の沢木みずほさんによると、中毒性の秘密はスープにあるのだという。とくにインスタントラーメンのスープは、さまざまな食材のエキスが含まれており、刺激の強い旨みに慣れてしまうと、天然のかつおぶしや煮干しで取っただしでは満足できなくなるのだそうだ（NEWSポストセブン）。
インスタントでなければ良いかというとそうでもなく、糖尿病専門医の市原由美江さんによるととんこつラーメンはリスクが高…